Kiniksa Pharmaceuticals
KNSA
#2410
Rank
A$11.11 B
Marketcap
๐Ÿ‡ง๐Ÿ‡ฒ
Country
A$141.52
Share price
-0.06%
Change (1 day)
123.15%
Change (1 year)

EPS for Kiniksa Pharmaceuticals (KNSA)

EPS in 2026 (TTM): A$2.07

According to Kiniksa Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A$2.13. In 2025 the company made an earnings per share (EPS) of A$1.19 an increase over its 2024 EPS that were of A-$0.91.

EPS history for Kiniksa Pharmaceuticals from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$2.0774.02%
2025A$1.19-231.15%
2024A-$0.91-421.05%
2023A$0.28-92.8%
2022A$3.93-214.78%
2021A-$3.42-10.85%
2020A-$3.84-14.57%
2019A-$4.506.33%
2018A-$4.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.01-194.41%๐Ÿ‡บ๐Ÿ‡ธ USA